MegaCHOEP Phase III

Motivation:

The goal of the study was to evaluate the therapeutic efficacy of a high-dose therapy with autologous stem cell therapy.

Description:

Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.

Help
help Creators and Submitter
Creator
Submitter
Activity

Views: 1011

Created: 20th May 2019 at 11:56

Last updated: 20th May 2019 at 11:56

Related items

Powered by
(v.1.12.0-master)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig

By continuing to use this site you agree to the use of cookies